|
|
|
|
|
|
|
|
|
|
EXCLUSIVE INSIGHTS:
|
|
|
|
|
| In the recorded expert discussion, the management team at DiaMonTech AG explains how their laser technology is changing the future of diabetes diagnostics. |
|
|
|
|
|
|
|
|
|
|
|
|
DiaMonTech AG's financing round is imminent - and you have the opportunity to subscribe for real shares in a multiple award-winning DeepTech startup starting at EUR 250.
Companisto business angels and renowned co-investors - including Samsung - have already committed over EUR 6.5 million in the current round.
The majority of the shares have already been subscribed. Demand is high - the round can be closed at any time after the start. Therefore, today you have the exclusive opportunity to gain a first impression of DiaMonTech before the start. |
|
|
|
|
|
|
|
|
|
|
|
| WHY INVEST IN DIAMONTECH AG? |
|
|
|
|
| • |
|
Shareholding: Subscribe to shares from as little as EUR 250. |
|
|
| • |
|
Co-investment with Samsung: EUR 1.5 million from the global technology group. |
|
|
| • |
|
Non-invasive glucose measurement without pricking: Worldwide patented laser technology. |
|
|
| • |
|
Over 100 patents and patent applications: Strong IP positioning. |
|
|
| • |
|
Internationally sought-after start-up: investors from South Korea, Ireland, Japan, Germany, the USA and Dubai. |
|
|
| • |
|
Billion-dollar diabetes market: market entry in the USA is imminent. |
|
|
|
|
|
|
|
|
|
|
|
 |
|
INFORMED IN GOOD TIME:
WITH THE COMPANISTO APP |
|
|
|
|
To make sure you don't miss the start of the DiaMonTech AG round, you will receive the notification of the official start of the round directly via the Companisto app.
Download the app now and activate push notifications: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Download our app |
|
| The Companisto app makes investing even easier |
|
|
|
|
|
|
|
|
|
|
|
| Companisto GmbH |
|
Köpenicker Str. 154, 10997 Berlin
Managing Director: Tamo Zwinge, LL. M. and David Rhotert
Amtsgericht: Berlin Charlottenburg HRB 132811 B
VAT-ID: DE 276 014 929
Phone: +49 30 330 837 49
Email: service@companisto.com |
|
|
|
|
|
|
|
|
| You receive this newsletter because you have subscribed to it. You can unsubscribe at any time via the unsubscribe link. |
|
| The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity. |
|
|
|
|
